RGEN
Repligen Corp
Price:  
171.94 
USD
Volume:  
456,296.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGEN Relative Valuation

-84.7%
Upside

As of 2024-05-19, the Relative Valuation of Repligen Corp (RGEN) is 26.29 USD. This relative valuation is based on P/E multiples. With the latest stock price at 171.94 USD, the upside of Repligen Corp based on Relative Valuation is -84.7%.

The range of the Relative Valuation is 9.60 - 45.10 USD.

Range Selected
Trailing P/E multiples 36.0x - 39.4x 37.2x
Forward P/E multiples 33.7x - 37.7x 35.7x
Fair Price 9.60 - 45.10 26.29
Upside -94.4% - -73.8% -84.7%
171.94 USD
Stock Price
26.29 USD
Fair Price

RGEN Relative Valuation - Historical P/E Data

Date P/E
2024-05-17 644.11
2024-05-16 640.70
2024-05-15 659.43
2024-05-14 646.13
2024-05-13 611.89
2024-05-10 624.89
2024-05-09 617.70
2024-05-08 619.99
2024-05-07 628.30
2024-05-06 629.50
2024-05-03 625.79
2024-05-02 623.02
2024-05-01 593.24
2024-04-30 615.12
2024-04-29 622.38
2024-04-26 624.03
2024-04-25 620.59
2024-04-24 628.83
2024-04-23 641.64
2024-04-22 589.94
2024-04-19 588.67
2024-04-18 588.37
2024-04-17 603.05
2024-04-16 615.00
2024-04-15 623.32
2024-04-12 642.58
2024-04-11 659.62
2024-04-10 659.32
2024-04-09 681.50
2024-04-08 652.02
2024-04-05 651.12
2024-04-04 647.86
2024-04-03 664.27
2024-04-02 666.51
2024-04-01 685.36
2024-03-28 688.99
2024-03-27 692.10
2024-03-26 688.69
2024-03-25 692.59
2024-03-22 741.85
2024-03-21 748.25
2024-03-20 736.94
2024-03-19 744.32
2024-03-18 727.69
2024-03-15 711.50
2024-03-14 725.18
2024-03-13 728.21
2024-03-12 722.11
2024-03-11 723.53
2024-03-08 732.26